切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2014, Vol. 08 ›› Issue (05) : 365 -369. doi: 10.3877/cma.j.issn.1674-0793.2014.05.007

所属专题: 文献

论著

高尔基体糖蛋白73检测对原发性肝癌的诊断价值探讨
李新丰,1, 周文瑞1, 王高雄1, 李承中1, 黄天从1   
  1. 1. 362000 泉州,福建医科大学附属第二医院肝胆胰外科
  • 收稿日期:2014-04-15 出版日期:2014-10-01
  • 通信作者: 李新丰
  • 基金资助:
    福建省医学创新课题资助项目(2012-CXB-22)

Diagnosis value of Golgi protein 73 detection for primary hepatic carcinoma

Xinfeng Li,1, Wenrui Zhou1, Gaoxiong Wang1, Chengzhong Li1, Tiancong Huang1   

  1. 1. Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
  • Received:2014-04-15 Published:2014-10-01
  • Corresponding author: Xinfeng Li
  • About author:
    Corresponding author: Li Xinfeng, Email:
引用本文:

李新丰, 周文瑞, 王高雄, 李承中, 黄天从. 高尔基体糖蛋白73检测对原发性肝癌的诊断价值探讨[J/OL]. 中华普通外科学文献(电子版), 2014, 08(05): 365-369.

Xinfeng Li, Wenrui Zhou, Gaoxiong Wang, Chengzhong Li, Tiancong Huang. Diagnosis value of Golgi protein 73 detection for primary hepatic carcinoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2014, 08(05): 365-369.

目的

研究高尔基体糖蛋白73(GP73)、甲胎蛋白(AFP)、血管内皮生长因子(VEGF)在原发性肝癌(PHC)患者血清中的表达意义。

方法

43例PHC及9例肝良性肿瘤患者接受双抗体夹心ELISA法检测血清GP73、VEGF浓度及电化学发光法检测血清AFP浓度。

结果

GP73在不同年龄、性别、肿瘤大小间的表达差异无统计学意义。伴乙肝病毒携带的患者其GP73表达水平高于不伴有乙肝病毒携带的患者(P<0.05),伴有肝硬化的患者其GP73表达水平高于不伴有肝硬化的患者(P<0.05)。PHC组高于肝良性肿瘤组[(241.413±77.079)μg/L vs(101.866±74.192)μg/L,P<0.01]。手术前GP73、AFP和VEGF表达水平均高于手术后[(674.176±1 090.083)μg/L vs (178.560±289.330)μg/L,(256.666±164.760)μg/L vs(149.072±158.643)μg/L,P<0.01]。AFP、GP73、VEGF在PHC鉴别诊断的ROC曲线下面积分别为0.894、0.791、0.612,GP73面积为最大。GP73诊断PHC组敏感性及特异性为88.4%、77.7%,高于AFP。将AFP及GP73并联检测后发现,敏感度为96.8%,特异度为63.7%,与单项检测相比,GP73联合AFP可明显提高PHC诊断的准确性。

结论

GP73是一种灵敏度、特异度更高的PHC诊断的血清标志物,而GP73、AFP联合检测可提高PHC诊断准确性。

Objective

To investigate the expression and clinical significance of serum Golgi protein 73 (GP73) , Alpha-fetoproteins (AFP) and vascular endothelial growth factor (VEGF) in primary hepatic cancer (PHC) patients.

Methods

Serum AFP, GP73 and VEGF levels of forty-three PHC patients and 9 patients with benign hepatic tumor were detected by electrochemiluminescence and double antibody sandwich ELISA.

Results

The serum levels of GP73 in different ages, gender, tumor sizes was not significantly different. The serum level of GP73 in hepatitis B virus carriers was significantly higher than no hepatitis B virus carriers, and that in hepatic cirrhosis group was significantly higher than no cirrhosis group (P<0.05) . The serum level of GP73 in PHC group was significantly higher than benign liver tumor group[ (241.413±77.079) vs (101.866±74.192) μg/L, P<0.01]. The serum levels of GP73 , AFP and VEGF before the operation were significantly higher than those after the operation [ (247.231±77.009) μg/L vs (128.334±92.235)μg/L, (674.176±1090.083) μg/L vs(178.560±289.330)μg/L,(256.666±164.76) μg/L vs (149.072±158.643) μg/L, all P<0.01]. The area of AFP, GP73, VEGF under the ROC curve in the differential diagnosis of PHC were 0.894, 0.791, 0.612. The sensitivity and specificity value of GP73 were 88.4% and 77.7%, higher than those of AFP. The sensitivity and specificity value of AFP combined with GP73 reached 96.8% and 63.7%, higher than either single detection.

Conclusion

GP73 is a sensitivity and specificity PHC diagnostic serum markers. AFP combined with GP73 detection has higher accuracy for PHC diagnosis.

图1 GP73浓度计算标准曲线
图2 VEGF浓度计算标准曲线
表1 不同组别之间血清GP73水平的比较(μg/L,t检验)
表2 两组患者之间血清GP73、VEGF、AFP的水平比较(μg/L,t检验,±s
表3 43例PHC组患者手术前后血清GP73、VEGF、AFP比较(μg/L,t检验,±s
图3 AFP单独及联合GP73诊断PHC的真实性和可靠性对比
图4 GP73、AFP、VEGF诊断肝癌的ROC曲线
[1]
Tamura Y,Igarashi M,Suda T, et al. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment[J]. Dig Dis Sci, 2010, 55(7): 2095-2101.
[2]
Sterling RK,Wright EC,Morgan TR, et al. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C[J]. Am J Gastroenterol, 2012, 107(1): 64-74.
[3]
Kladney RD,Bulla GA,Guo L, et al. GP73, a novel golgi - localized protein upregulated by viral infection[J]. Gene, 2000, 249(1): 53-65.
[4]
Tian L,Wang Y,Xu D, et al. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases[J]. Int J Cancer, 2011, 129(8): 1923-1931.
[5]
李利军,李新丰,王高雄, 等. GP73联合AFP、VEGF检测对原发性肝癌的诊断价值[J]. 世界华人消化杂志, 2009, 17(29): 3056-3060.
[6]
Abelev GI,Perova SD,Khramkova NI, et al. Production of embryonal alpha-globulin by transplantable mouse hepatomas[J]. Transplantation, 1963, 1: 174-180.
[7]
Ruoslahti E,Seppala M. Studies of carcino-fetal proteins.3. DeveloPment of a Radioimmunoassay for-fetoprotein.Demonstration of-fetoprotein in serum of healthy human adults[J]. Int J Cancer, 1971, 8(3): 374-383.
[8]
Hu JS,Wu DW,Liang S, et al. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population[J]. Med Oneol, 2010, 27(2): 339-345.
[9]
Marrero JA,Romano PR,Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma[J]. J Hepatol, 2005, 43(6): 1007-1012.
[10]
Zhou Y,Yin X,Ying J, et al. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis[J]. BMC Cancer, 2012 , 16 (12) :17-20.
[11]
Tian L,Wang Y,Xu D, et al. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases[J]. Int J Cancer, 2011, 129(8): 1923-1931.
[12]
Stefaniuk P,Cianciara J,Wiercinska -Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma[J]. World J Gastroenterol, 2010, 16(4): 418-424.
[13]
Poon RT,Lau C,Pang R, et al. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies[J]. Ann Surg Oncol, 2007, 14(6): 1835-1845.
[1] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[2] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[3] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[4] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[5] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[6] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[7] 马立伟, 贾志强, 陈午盛, 邵明亮, 刘琼, 段玉松. CalliSpheres载药微球联合碘化油治疗肝癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 369-372.
[8] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
[9] 张敏龙, 杨翠平, 王博, 崔云杰, 金发光. MiR-200b-3p 通过抑制HIF-1α 表达减轻海水吸入诱导的肺水肿作用及机制[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 696-700.
[10] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[13] 周庆, 杨旭. 甲胎蛋白、纤维蛋白原与前白蛋白比值、癌胚抗原、D-二聚体对结肠癌术后复发的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 301-305.
[14] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[15] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
20
最新录用 在线预览 正式出版
0 0 20
  来源 本网站 其他网站
  次数 7 13
  比例 35% 65%